rs2287780
badMag 2.5This is a variant in the MTRR gene that changes a arginine to an cysteine.
Key Literature Trait Associations
Colorectal cancer
Two candidate-gene studies in predominantly European cohorts have examined rs2287780 (MTRR Arg415Cys) in relation to colorectal neoplasia. Koushik et al. (2006) found that carriers of the Cys415 variant allele had an OR of 2.03 (95% CI 1.15–3.56) for colorectal cancer compared to homozygous wild-type in the Nurses' Health Study / Health Professionals Follow-up Study. Hazra et al. (2007) reported a suggestive association with advanced colorectal adenoma in women. Both studies are relatively small and lack genome-wide significance; large GWAS catalogs do not include this variant, so findings require confirmation in larger, independent populations.
Hepatocellular carcinoma
A Chinese case-control study (Zhang et al., 2015) of 1,500 HCC patients and 1,500 controls found that MTRR rs2287780 was significantly associated with hepatocellular carcinoma risk in a Chinese population (p range 2.26×10⁻⁴–0.035 across six one-carbon pathway SNPs). The study was conducted in a hepatitis B virus (HBV)-endemic setting and participants were matched by age, sex, and HBV status. Specific OR and confidence interval for rs2287780 alone were not reported in the abstract. Evidence is limited to this single candidate-gene study in an East Asian population and has not been replicated or confirmed in GWAS.
Methionine Synthase Reductase Activity
The MTRR R415T variant (rs2287780) is a rare missense polymorphism (Arg415Thr) in methionine synthase reductase (~4% global frequency). The T allele changes an arginine to threonine residue. Limited published evidence exists for independent clinical significance.
▶ClinVar annotation
Disorders of Intracellular Cobalamin Metabolism; Methylcobalamin deficiency type cblE (HMAE); not specified
View on ClinVar →Gene information from NCBI Gene. Variant classifications from ClinVar.
Community Wiki
No community notes yet for this variant. Sign in to start one.
Comments
Sign in to join the discussion.
Loading comments…